Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer
- 1 May 1996
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 347 (9011), 1279-1284
- https://doi.org/10.1016/s0140-6736(96)90936-8
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Responsiveness of a Single-Item Indicator Versus a Multi-Item ScaleMedical Care, 1996
- Quality of life and clinical trialsThe Lancet, 1995
- Sudden fall in breast cancer death rates in England and WalesThe Lancet, 1995
- Timing of baseline quality of life assessment in an international adjuvant breast cancer trial: Its effect on patient self-estimationAnnals of Oncology, 1994
- Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic malignant melanomaEuropean Journal Of Cancer, 1993
- Quality of life measures for patients receiving adjuvant therapy for breast cancer: an international trialEuropean Journal Of Cancer, 1992
- On the receiving end — III Measurement of quality of life during cancer chemotherapyAnnals of Oncology, 1990
- Improving the Quality of Life during Chemotherapy for Advanced Breast CancerNew England Journal of Medicine, 1987
- On the receiving end—II. Linear analogue self-assessment (LASA) in evaluation of aspects of the quality of life of cancer patients receiving therapyEuropean Journal of Cancer and Clinical Oncology, 1983
- EVALUATION OF QUALITY OF LIFE IN PATIENTS RECEIVING TREATMENT FOR ADVANCED BREAST CANCERThe Lancet, 1976